Methods and reagents for treatment and diagnosis of age-related macular degeneration

Details for Australian Patent Application No. 2006214320 (hide)

Owner University of Iowa Research Foundation

Inventors Smith, Richard J.; Hageman, Gregory S.

Agent Spruson & Ferguson

Pub. Number AU-B-2006214320

PCT Pub. Number WO2006/088950

Priority 60/653,078 14.02.05 US; 60/735,697 09.11.05 US; 60/717,861 16.09.05 US; 60/715,503 09.09.05 US

Filing date 14 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 7 July 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/088950 Priority application(s): WO2006/088950

7 July 2011 Application Accepted

  Published as AU-B-2006214320

3 November 2011 Standard Patent Sealed

23 February 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 22 Dec 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

5 July 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 22 Dec 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214321-CD38 modulated chemotaxis

2006214319-Fused heterocyclic compounds useful as inhibitors of histone deacetylase